|
UNITED STATES | |||
|
SECURITIES AND EXCHANGE COMMISSION | |||
|
Washington, D.C. 20549 | |||
|
| |||
|
SCHEDULE 14A INFORMATION | |||
|
| |||
|
Proxy Statement Pursuant to Section 14(a) of | |||
|
| |||
|
Filed by the Registrant x | |||
|
| |||
|
Filed by a Party other than the Registrant o | |||
|
| |||
|
Check the appropriate box: | |||
|
o |
Preliminary Proxy Statement | ||
|
o |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | ||
|
o |
Definitive Proxy Statement | ||
|
x |
Definitive Additional Materials | ||
|
o |
Soliciting Material under §240.14a-12 | ||
|
| |||
|
Bristol-Myers Squibb Company | |||
|
(Name of Registrant as Specified In Its Charter) | |||
|
| |||
|
| |||
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant) | |||
|
| |||
|
Payment of Filing Fee (Check the appropriate box): | |||
|
x |
No fee required. | ||
|
o |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | ||
|
|
(1) |
Title of each class of securities to which transaction applies: | |
|
|
|
| |
|
|
(2) |
Aggregate number of securities to which transaction applies: | |
|
|
|
| |
|
|
(3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | |
|
|
|
| |
|
|
(4) |
Proposed maximum aggregate value of transaction: | |
|
|
|
| |
|
|
(5) |
Total fee paid: | |
|
|
|
| |
|
o |
Fee paid previously with preliminary materials. | ||
|
o |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | ||
|
|
(1) |
Amount Previously Paid: | |
|
|
|
| |
|
|
(2) |
Form, Schedule or Registration Statement No.: | |
|
|
|
| |
|
|
(3) |
Filing Party: | |
|
|
|
| |
|
|
(4) |
Date Filed: | |
|
|
|
| |
*** Exercise Your Right to Vote *** Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Shareholders to Be Held on May 2, 2017. BRISTOL-MYERS SQUIBB COMPANY You are receiving this communication because you hold shares in the company named above. P.O. BOX 4000 PRINCETON, NJ 08540 This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side). We encourage you to access and review all of the important information contained in the proxy materials before voting. proxy materials and voting instructions. E22763-P86099-Z69327 See the reverse side of this notice to obtain Meeting Information Meeting Type:Annual Meeting of Shareholders For holders as of:March 14, 2017 Date: May 2, 2017Time: 10:00 A.M. Location: Bristol-Myers Squibb Company 3401 Princeton Pike Lawrence Township, NJ 08648 For directions to the meeting, please see the inside back cover of the Proxy Statement or call the company at (609) 302-3000.
Before You Vote How to Access the Proxy Materials Have the information that is printed in the box marked by the arrow XXXX XXXX XXXX XXXX (located on the by the arrow XXXX XXXX XXXX XXXX (located on the following page) in the subject line. How To Vote Please Choose One of the Following Voting Methods E22764-P86099-Z69327 Vote In Person: Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares. Vote By Internet: To vote now by Internet, go to WWW.PROXYVOTE.COM. Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m., Eastern Time either on (i) April 27, 2017 for shares in employee benefit plans, or (ii) May 1, 2017 for all other shares. Have this Notice in hand when you access the website and follow the instructions. Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a proxy card. Proxy Materials AAvvaaiillaabbllee ttooVVIEIEWWoorrRREECCEEIVIVEE: : 1. NOTICE OF 2017 ANNUAL MEETING 2. PROXY STATEMENT3. ANNUAL REPORT How to View Online: following page) and visit: www.proxyvote .com. How to Request and Receive a PAPER or E-MAIL Copy: If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request: 1) BY INTERNET: www.proxyvote.com 2) BY TELEPHONE: 1-800-579-1639 3) BY E-MAIL*: sendmaterial@proxyvote.com * If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. To facilitate timely delivery, please make the request as instructed above on or before 4/18/17.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" EACH DIRECTOR UNDER ITEM 1. THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" ITEM 2. 1. Election of Directors Nominees: 2. Advisory Vote to Approve the Compensation of our Named Executive Officers THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR "1 YEAR" on ITEM 3. 1A) P. J. Arduini 3. Advisory Vote on the Frequency of the Advisory Vote to Approve the Compensation of our Named Executive Officers 1B) R. J. Bertolini 1C) G. Caforio, M.D. THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" ITEMS 4, 5 and 6. 1D) M. W. Emmens 4. Re-approval of the Materials Terms of the Performance-Based Awards under the Company's 2012 Stock Award and Incentive Plan (as amended) Approval of an Amendment to the Company's 2012 Stock Award and Incentive Plan Ratification of the Appointment of Independent Registered Public Accounting Firm 1E) L. H. Glimcher, M.D. 1F) M. Grobstein 5. 1G) A. J. Lacy 6. 1H) D. C. Paliwal THE BOARD OF DIRECTORS RECOMMENDS A VOTE "AGAINST" ITEM 7. 1I) T. R. Samuels 7. Shareholder Proposal to Lower the Share Ownership Threshold to Call Special Shareholder Meetings 1J) G. L. Storch 1K) V. L. Sato, Ph.D. E22765-P86099-Z69327 Voting Items
E22766-P86099-Z69327
